.Pharmacolibrary.Drugs.ATC.J.J06BB02 .Pharmacolibrary.Drugs.ATC.J.J06BB02| name: | TetanusImmunoglobulin | |
| ATC code: | J06BB02 | route: | intramuscular |
| compartments: | 1 | |
| dosage: | 250 | mg |
| volume of distribution: | 0.15 | L |
| clearance: | 0.0035 | L/kg/h |
| other parameters in model implementation | ||
Tetanus immunoglobulin (TIG) is a human immunoglobulin preparation that provides passive immunity against tetanus toxin. It is used both for post-exposure prophylaxis following potential exposure to Clostridium tetani and for treatment of tetanus by neutralizing unbound toxin. It is an approved medicine and is still used today for these purposes.
Pharmacokinetic parameters estimated for healthy adult population, based on typical dosing and published reviews. No direct clinical pharmacokinetic modeling data identified in literature.